Led end-to-end product design for 25+ AI-native SaaS platforms, leveraging a proprietary Large Experience Model (LXM) to automate SMB workflows across pharma, fintech, e-commerce, and resource management.

Accelerated MVP delivery by 30% by translating product strategy into execution-ready designs and aligning roadmaps across engineering, product, and client teams.

Increased client conversion by 25% through data-informed UX decisions, rapid prototyping, and onboarding and core workflow optimization.

Established and scaled cross-platform design systems with accessibility and brand governance, reducing rework and supporting multi-product SaaS expansion.

Influenced executive-level UX and product decisions supporting enterprise contracts with Amazon, PAC Group, Amneal Pharmaceuticals, and others.

Owned end-to-end redesign of Pilgrim’s D2C eCommerce platform, driving $300K+ incremental revenue within the first week post-launch.

Architected conversion-focused user journeys across discovery-to-checkout, increasing purchase completion and improving NPS by 32%.

Led CRO initiatives using experimentation and game-based campaign experiences, increasing campaign engagement by 36% during peak drops.

Defined and executed an experimentation roadmap across key funnels using A/B testing and performance metrics to drive revenue and retention.

Partnered directly with founders and growth teams to align UX strategy with monetization and customer lifetime value.

Defined UX strategy for FinTech and resource management products, driving 24% MAU growth through data-driven experience improvements.

Led executive UX audits and competitive analysis supporting $2M+ funding outcomes.

Mentored and managed an 8-member UX team, improving conversion rates by 90% and reducing churn across client platforms.

Led UX strategy for a 1M+ user FinTech platform, contributing to a $75M acquisition by PhonePe India.

Implemented scalable design systems and improved on-time sprint delivery by 15%.

Mentored 18+ designers, increasing design approval success rates by 40%.